Redhill Biopharma
RDHL
#10210
Rank
โ‚ฌ3.78 M
Marketcap
2,91ย โ‚ฌ
Share price
-5.14%
Change (1 day)
-77.23%
Change (1 year)

Earnings for Redhill Biopharma (RDHL)

Earnings in 2023 (TTM): โ‚ฌ6.97 Million

According to Redhill Biopharma's latest financial reports the company's current earnings are โ‚ฌ35.74 Million. In 2022 the company made an earning of -โ‚ฌ66.44 Million, an increase over its 2021 earnings that were of -โ‚ฌ90.61 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Redhill Biopharma from 2012 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) โ‚ฌ6.97 M-110.5%
2022 -โ‚ฌ66.44 Million-26.68%
2021 -โ‚ฌ90.61 Million28.32%
2020 -โ‚ฌ70.62 Million80.06%
2019 -โ‚ฌ39.22 Million8.97%
2018 -โ‚ฌ35.99 Million-14.76%
2017 -โ‚ฌ42.22 Million55.07%
2016 -โ‚ฌ27.23 Million39.26%
2015 -โ‚ฌ19.56 Million96.9%
2014 -โ‚ฌ9.93 Million0.78%
2013 -โ‚ฌ9.86 Million16.93%
2012 -โ‚ฌ8.43 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚ฌ7.36 B 68,531.52%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚ฌ13.87 B 129,289.91%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ3.86 B 35,942.78%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ40.53 M 277.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
-โ‚ฌ0.27 Billion-2,536.92%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel